Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The CABANA pilot study is designed to test the hypothesis that the treatment strategy of
percutaneous left atrial catheter ablation for the purpose of the elimination of atrial
fibrillation (AF) is superior to current state-of-the-art therapy with either rate control or
anti-arrhythmic drugs for reducing AF recurrences at 1 year follow-up.
Phase:
N/A
Details
Lead Sponsor:
Mayo Clinic
Collaborators:
Abbott Medical Devices Duke Clinical Research Institute St. Jude Medical